Chimin(SH:603222) Cai Jing Wang·2026-01-26 07:37Core Viewpoint - Jimin Health (603222) expects a net loss of 210 million to 250 million yuan for 2025, which is an increase compared to the previous year's loss of 59.71 million yuan [1] Financial Performance - The company anticipates a non-recurring net loss of 205 million to 245 million yuan for 2025 [1] - The company has recognized an inventory impairment provision of approximately 37 million yuan for its pre-filled catheter flushing devices and safety syringes [1] Legal and Compliance Issues - Due to the case involving the forgery of company seals by He Qinghong and others, the company has confirmed related losses of approximately 38 million yuan [1] Asset Valuation - The performance of Ezhou Second Hospital is expected to decline in 2025, leading the company to recognize a goodwill impairment provision of approximately 20 million yuan [1] - After this provision, the cumulative impairment recognized will be approximately 136 million yuan, with a remaining book value of about 15.14 million yuan [1]